Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 1/2020

01-01-2020 | Cytostatic Therapy | Editorial

Editorial

Author: Jan H. Beumer

Published in: Cancer Chemotherapy and Pharmacology | Issue 1/2020

Login to get access

Excerpt

Cancer Chemotherapy and Pharmacology is a high-quality journal that has always delivered exactly what the title promises thanks to the careful editing by Professors Etienne Chatelut, Ed Sausville, Herbie Newell, Hilary Calvert, and my late mentor Merrill Egorin, and before them the founding editors Tim McElwain, George Mathe and Steve Carter. …
Metadata
Title
Editorial
Author
Jan H. Beumer
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Cancer Chemotherapy and Pharmacology / Issue 1/2020
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-020-04032-0

Other articles of this Issue 1/2020

Cancer Chemotherapy and Pharmacology 1/2020 Go to the issue

Original Article

Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia

Original Article

Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials

Original Article

Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma

Original Article

Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan

Original Article

Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)

Original Article

Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits